What Do the New EU CLP Timelines Mean For Substances Identified As Hazardous Under Other Legislation?
The revised CLP Regulation allows certain hazard assessments carried out under other EU legislation, including REACH, the Biocidal Products Regulation and the Plant Protection Products Regulation, to be integrated directly into harmonised classifications.
The changes aim to reduce duplication, support the EU’s ‘one substance, one assessment’ approach and accelerate the regulation of endocrine disruptors, PBT and vPvB substances.
The European Union regulatory framework for chemicals continues to evolve towards greater integration and efficiency. One of the most important recent developments concerns the incorporation of hazard assessments performed under different pieces of EU legislation into the framework established by Regulation (EC) No 1272/2008.
The European Chemicals Agency (ECHA) has published guidance concerning “Timelines for substances identified as hazardous under other legislation,” explaining how substances already assessed under various EU regulatory systems may be incorporated into harmonised classification and labelling procedures.
This mechanism was introduced as part of the revision of the CLP Regulation and aims to avoid duplication of scientific work while ensuring faster and more coherent regulation of hazardous substances throughout the European Union.
The initiative is particularly relevant for substances identified as:
- Endocrine disruptors (ED);
- Persistent, bioaccumulative and toxic substances (PBT);
- Very persistent and very bioaccumulative substances (vPvB).
The approach has major implications for industries including cosmetics, chemicals, pharmaceuticals, biocides, plant protection products, packaging, and consumer goods.
This article examines the legal background, timelines, regulatory mechanisms, and practical implications associated with the integration of hazard assessments performed under other EU legislation into the CLP system.
What Is the Role Of the CLP Regulation In EU Chemical Classification?
Regulation (EC) No 1272/2008 governs the classification, labelling, and packaging of substances and mixtures within the European Union.
The Regulation implements the United Nations Globally Harmonised System (GHS) and ensures consistent communication of chemical hazards throughout the supply chain.
Under CLP, hazardous substances must be classified according to specific hazard classes and categories. Once classified, substances require appropriate labels, hazard statements, pictograms, and packaging measures.
Historically, harmonised classification under Annex VI to CLP involved dedicated scientific assessment procedures that could be lengthy and resource-intensive.
However, several other EU legislative frameworks already conduct extensive hazard assessments for substances. These include:
- REACH Regulation;
- Biocidal Products Regulation;
- Plant Protection Products Regulation.
The revised CLP framework now seeks to use those existing assessments more efficiently.
How Are Hazard Assessments Integrated Into the CLP Regulation?
The revised CLP Regulation introduced Article 37(7), establishing a mechanism that allows the European Commission to directly incorporate certain hazard identifications into Annex VI of CLP when equivalent scientific assessments have already been completed under other legislation.
This mechanism primarily concerns substances identified as:
- Endocrine disruptors;
- PBT substances;
- vPvB substances.
The rationale is straightforward: if a substance has already undergone a rigorous scientific evaluation under REACH, the Biocidal Products Regulation, or the Plant Protection Products Regulation, repeating essentially the same assessment under CLP would waste resources and delay risk management actions.
The integration mechanism therefore supports regulatory consistency while accelerating the identification and communication of hazards.
This approach reflects a broader trend in EU chemicals regulation towards “one substance, one assessment,” aiming to improve coordination between agencies and legislative systems.
What Are the Timelines and Transitional Measures Under the Revised CLP Regulation?
ECHA’s guidance on timelines is particularly important because many substances are currently undergoing assessment under different legislative frameworks.
The revised CLP system establishes transitional arrangements that determine how completed and ongoing evaluations are transferred into CLP harmonised classification procedures.
Different timelines apply depending on the stage of the assessment process.
Where a substance has already been formally identified under REACH, BPR, or PPPR as possessing endocrine-disrupting or PBT/vPvB properties before specific cut-off dates, the European Commission may directly add the relevant classification to Annex VI of CLP.
For ongoing assessments, transitional provisions determine whether the original evaluating authority completes the assessment or whether the process shifts into the CLP framework.
These timelines are important because they affect:
- Regulatory obligations;
- Market access;
- Safety data sheet updates;
- Supply chain communication;
- Product reformulation strategies.
Companies must therefore monitor both CLP developments and hazard assessments conducted under other legislation.
What Are the New CLP Hazard Classes For Endocrine Disruptors and Persistent Substances?
One of the most significant developments in the revised CLP Regulation concerns the introduction of new hazard classes under Commission Delegated Regulation (EU) 2023/707.
These include hazard classes for:
- Endocrine disruption affecting human health;
- Endocrine disruption affecting the environment;
- Persistent, mobile and toxic substances (PMT);
- Very persistent, very mobile substances (vPvM).
The introduction of endocrine disruptor classifications is particularly important for sectors such as cosmetics, food contact materials, pesticides, and biocides.
Substances identified as endocrine disruptors under the Biocidal Products Regulation or Plant Protection Products Regulation may now transition more rapidly into harmonised CLP classifications.
This has significant legal and commercial consequences because harmonised classification often triggers additional obligations under other EU legislation.
For example, endocrine disruptor classifications may influence:
- Cosmetic ingredient restrictions;
- REACH authorisation procedures;
- Occupational exposure controls;
- Consumer communication obligations;
- Sustainability assessments.
How Does the Revised CLP Framework Interact with REACH and SVHC Identification?
The interaction between CLP and REACH is becoming increasingly interconnected.
Substances identified as hazardous under CLP may subsequently become candidates for inclusion on the REACH Candidate List of Substances of Very High Concern (SVHCs).
SVHC identification may apply to:
- Carcinogenic, mutagenic, or toxic for reproduction (CMR) substances;
- PBT or vPvB substances;
- Endocrine disruptors;
- Substances causing equivalent levels of concern.
Once included on the Candidate List, substances trigger immediate legal obligations concerning communication, safety data sheets, and SCIP notifications.
The new integration mechanism therefore accelerates the pathway from scientific hazard identification to broader regulatory control.
Industries using substances with potential endocrine-disrupting or persistent properties must carefully monitor ongoing assessments because classification outcomes may rapidly lead to wider compliance obligations.
What Are the Implications of the Revised CLP Framework For Industry?
The accelerated integration of hazard assessments has substantial implications for industry.
Companies may face shorter timelines for adapting to new classifications and risk management obligations. This can affect:
- Product formulations;
- Raw material sourcing;
- Packaging compliance;
- Safety data sheets;
- Labelling updates;
- Toxicological assessments.
Sectors particularly exposed include cosmetics, plastics, coatings, electronics, food packaging, textiles, and specialty chemicals.
Many businesses are increasingly adopting proactive chemical management strategies to anticipate future restrictions rather than waiting for formal regulatory action.
The trend also reinforces the importance of alternatives assessment and safer-by-design approaches.
Companies relying on substances currently under evaluation for endocrine-disrupting or PBT properties may need to consider substitution plans well before regulatory deadlines take effect.
What Does the Future of Integrated Chemical Regulation Look Like In the EU?
The integration of hazard assessments into CLP reflects the EU’s broader objective of increasing regulatory efficiency.
The European Commission and ECHA aim to reduce duplication while ensuring faster protection of human health and the environment.
The “one substance, one assessment” philosophy may eventually lead to even greater integration among EU regulatory systems, including pharmaceuticals, cosmetics, food safety, occupational health, and environmental protection.
Digitalisation and improved data-sharing mechanisms are also expected to support this process.
At the same time, challenges remain. Scientific assessment of endocrine disruption and persistence can be highly complex, involving evolving methodologies and substantial data requirements.
Industry stakeholders have expressed concerns regarding legal predictability, transitional timelines, and the availability of suitable alternatives for certain substances.
Nevertheless, the regulatory direction is clear: the EU intends to accelerate the identification and management of hazardous substances while promoting their substitution with safer alternatives.
Conclusion: The future of Hazardous Substance Classification Under the EU CLP Regulation
European Chemicals Agency guidance on timelines for substances identified as hazardous under other legislation marks an important step towards a more integrated and efficient EU chemicals regulatory system.
By allowing hazard assessments already completed under REACH, the Biocidal Products Regulation, and the Plant Protection Products Regulation to feed directly into CLP harmonised classifications, the EU aims to avoid duplication, accelerate regulatory action, and strengthen protection of health and the environment.
The introduction of new hazard classes for endocrine disruptors and persistent substances further increases the significance of these developments.
For industry, the implications are substantial. Faster classification processes may rapidly trigger downstream obligations affecting product compliance, supply chains, market access, and sustainability strategies.
Businesses must therefore maintain active regulatory surveillance and anticipate future hazard classifications well in advance.
Companies adopting proactive substitution and safer-by-design strategies will likely be better positioned to navigate the increasingly stringent EU chemicals landscape.
Ultimately, the evolving interaction between CLP and other EU legislation demonstrates the growing emphasis on integrated chemicals management as a cornerstone of European environmental and public health policy.
Contact us, and we will be happy to help you keep your products compliant in all relevant markets.
Key Takeaways on EU CLP Timelines and Hazardous Substances
- The revised CLP Regulation allows certain hazard assessments conducted under other EU legislation to be incorporated directly into CLP harmonised classifications.
- The integration mechanism primarily applies to endocrine disruptors (ED), persistent, bioaccumulative and toxic (PBT) substances, and very persistent and very bioaccumulative (vPvB) substances.
- The changes support the EU’s ‘one substance, one assessment’ approach by reducing duplication and improving regulatory efficiency.
- New harmonised classifications may rapidly trigger wider obligations under REACH and other EU legislation.
